These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8123469)

  • 1. Polymerase chain reaction allelotyping of human ovarian cancer.
    Osborne RJ; Leech V
    Br J Cancer; 1994 Mar; 69(3):429-38. PubMed ID: 8123469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An allelotype of squamous carcinoma of the head and neck using microsatellite markers.
    Ah-See KW; Cooke TG; Pickford IR; Soutar D; Balmain A
    Cancer Res; 1994 Apr; 54(7):1617-21. PubMed ID: 8137268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss in ovarian cancer.
    Yang-Feng TL; Han H; Chen KC; Li SB; Claus EB; Carcangiu ML; Chambers SK; Chambers JT; Schwartz PE
    Int J Cancer; 1993 Jun; 54(4):546-51. PubMed ID: 8099899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
    Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human epithelial ovarian cancer allelotype.
    Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
    Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumour tissue.
    Gruis NA; Abeln EC; Bardoel AF; Devilee P; Frants RR; Cornelisse CJ
    Br J Cancer; 1993 Aug; 68(2):308-13. PubMed ID: 8102243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.
    Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG
    Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
    Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
    Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity in ovarian cancer: detection by PCR and microsatellite polymorphism.
    Aguiari GL; Bianchi N; Cavazzini P; Martinello R; Lovato F; Mollica G; Piva R; del Senno L
    Boll Soc Ital Biol Sper; 1994 Apr; 70(4):125-8. PubMed ID: 8086156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of archival fine-needle aspirates for the allelotyping of tumors.
    Euhus DM; Maitra A; Wistuba II; Ashfaq R; Alberts A; Gibbons D; Gazdar AF
    Cancer; 1999 Dec; 87(6):372-9. PubMed ID: 10603191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.
    Allan GJ; Cottrell S; Trowsdale J; Foulkes WD
    Hum Mutat; 1994; 3(3):283-91. PubMed ID: 8019564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.
    Bandera CA; Takahashi H; Behbakht K; Liu PC; LiVolsi VA; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
    Cancer Res; 1997 Feb; 57(3):513-5. PubMed ID: 9012483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease.
    Rehman I; Quinn AG; Healy E; Rees JL
    Lancet; 1994 Sep; 344(8925):788-9. PubMed ID: 7916075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six microsatellite polymorphisms at candidate and confirmed tumour suppressor gene loci.
    Jones MH; Sato T; Saito H; Tanigami A; Nakamura Y
    Hum Mol Genet; 1994 Oct; 3(10):1911. PubMed ID: 7849726
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
    Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
    Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.